{"id":643065,"date":"2017-08-29T03:38:27","date_gmt":"2017-08-29T03:38:27","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/"},"modified":"2017-08-29T03:38:27","modified_gmt":"2017-08-29T03:38:27","slug":"gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/","title":{"rendered":"Gilead looks to acquire Kite Pharma for USD 11.9 bn"},"content":{"rendered":"

M&A WATCH- <\/strong>US pharma company Gilead reached an agreement to acquire Kite for USD 11.9 bn, according to the Financial Times<\/a>. Gilead \u2014 the maker of hepatitis C cure Sovaldi \u2014 is looking to get its hands on an experimental med which fights cancer by re-engineering the patient\u2019s white blood cells to attack the cancer. The company is willing to pay USD 180 per share to Kite Pharma. This is Gilead\u2019s largest takeover since it acquired Pharmasset for USD 11 bn six years ago.<\/p>\n","protected":false},"excerpt":{"rendered":"

M&A WATCH- US pharma company Gilead reached an agreement to acquire Kite for USD 11.9 bn, according to the Financial Times. Gilead \u2014 the maker of hepatitis C cure Sovaldi \u2014 is looking to get its hands on an experimental med which fights cancer by re-engineering the patient\u2019s white blood cells to attack the cancer. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-643065","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"61b9c800-aba2-4cd0-9aa0-d8e486148eb0","order":"0","is_powered_by":true,"section_story_id":"31e958e5-e1f7-4112-8c0c-09a9bb3cd501","story_type":"1","photo_url":"","photo_position":"above","related_issue":[643052],"teaser":"","voice_url":""},"yoast_head":"\nGilead looks to acquire Kite Pharma for USD 11.9 bn - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead looks to acquire Kite Pharma for USD 11.9 bn\" \/>\n<meta property=\"og:description\" content=\"M&A WATCH- US pharma company Gilead reached an agreement to acquire Kite for USD 11.9 bn, according to the Financial Times. Gilead \u2014 the maker of hepatitis C cure Sovaldi \u2014 is looking to get its hands on an experimental med which fights cancer by re-engineering the patient\u2019s white blood cells to attack the cancer. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-29T03:38:27+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Gilead looks to acquire Kite Pharma for USD 11.9 bn\",\"datePublished\":\"2017-08-29T03:38:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\"},\"wordCount\":91,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\",\"name\":\"Gilead looks to acquire Kite Pharma for USD 11.9 bn - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2017-08-29T03:38:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead looks to acquire Kite Pharma for USD 11.9 bn\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gilead looks to acquire Kite Pharma for USD 11.9 bn - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/","og_locale":"en_US","og_type":"article","og_title":"Gilead looks to acquire Kite Pharma for USD 11.9 bn","og_description":"M&A WATCH- US pharma company Gilead reached an agreement to acquire Kite for USD 11.9 bn, according to the Financial Times. Gilead \u2014 the maker of hepatitis C cure Sovaldi \u2014 is looking to get its hands on an experimental med which fights cancer by re-engineering the patient\u2019s white blood cells to attack the cancer. […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-08-29T03:38:27+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Gilead looks to acquire Kite Pharma for USD 11.9 bn","datePublished":"2017-08-29T03:38:27+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/"},"wordCount":91,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/","name":"Gilead looks to acquire Kite Pharma for USD 11.9 bn - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2017-08-29T03:38:27+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Gilead looks to acquire Kite Pharma for USD 11.9 bn"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":600998,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/02\/17\/eva-pharma-becomes-licensed-distributor-for-gilead-in-africa-as-egypt-becomes-expansion-hub\/","url_meta":{"origin":643065,"position":0},"title":"Eva Pharma becomes licensed distributor for Gilead in Africa as Egypt becomes expansion hub","author":"enterpriseam admin","date":"17 February 2019","format":false,"excerpt":"Gilead and EvaPharma will use Egypt as a distribution and manufacturing hub to expand into Africa: Eva Pharma will become a licensed distributor for biotech and pharma giant Gilead Sciences\u2019 products in Africa, CEO Riad Armanious said in a statement to the local press on Thursday. Armanious said Gilead has\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":647797,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/","url_meta":{"origin":643065,"position":1},"title":"Gilead looking to produce new hep C treatment in Egypt -Kabil","author":"enterpriseam admin","date":"21 May 2017","format":false,"excerpt":"Pharma producer Gilead Sciences is looking to produce a new hepatitis C treatment in Egypt jointly with a local manufacturer, Trade and Industry Minister Tarek Kabil says. According to Al Masry Al Youm, Kabil says Gilead wants to use Egypt as a gateway market to African nations. The medication still\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":602648,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/04\/02\/gilead-and-evapharma-to-introduce-new-hepatitis-c-drug-to-egypt-in-may\/","url_meta":{"origin":643065,"position":2},"title":"Gilead and EvaPharma to introduce new Hepatitis C drug to Egypt in May","author":"enterpriseam admin","date":"2 April 2019","format":false,"excerpt":"US pharma company Gilead International aims to introduce Vosevi, a Hepatitis C drug, to Egypt within the next two months, said Amgad Talaat, general manager of EvaPharma, Gilead\u2019s agent in Africa. Talaat said the drug, which will target patients who have not responded to available treatments such as Sovaldi, is\u2026","rel":"","context":"In "Health + Education"","block_context":{"text":"Health + Education","link":"https:\/\/enterpriseam.com\/egypt\/category\/health-education\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":575504,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/10\/18\/adq-holding-could-buy-amoun-pharma-for-usd-700-mn\/","url_meta":{"origin":643065,"position":3},"title":"ADQ Holding could buy Amoun Pharma for USD 700 mn","author":"enterpriseam admin","date":"18 October 2020","format":false,"excerpt":"M&A WATCH- The Emirates\u2019 ADQ Holding could buy Amoun Pharma for USD 700 mn: Abu Dhabi\u2019s sovereign wealth fund ADQ is eyeing Bausch Health\u2019s unit in Egypt, AmounPharma, ahead of a potential acquisition with a price tag that could be north of USD 700 mn, Bloomberg reports, citing people familiar\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":588634,"url":"https:\/\/enterpriseam.com\/egypt\/2023\/06\/14\/ma-boom-for-big-pharma\/","url_meta":{"origin":643065,"position":4},"title":"M&A boom for big pharma","author":"enterpriseam admin","date":"14 June 2023","format":false,"excerpt":"Pharma firms spent USD 85 bn on acquisitions in 5M 2023","rel":"","context":"In "PLANET FINANCE"","block_context":{"text":"PLANET FINANCE","link":"https:\/\/enterpriseam.com\/egypt\/planet-finance\/\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2023\/6\/699.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":634353,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/01\/14\/unnamed-uk-fund-makes-usd-600-mn-offer-to-buy-amoun\/","url_meta":{"origin":643065,"position":5},"title":"Unnamed UK fund makes USD 600 mn offer to buy Amoun","author":"enterpriseam admin","date":"14 January 2018","format":false,"excerpt":"M&A WATCH- An unnamed UK-based fund has made overtures to acquire Egyptian pharma company Amoun from its embattled Canadian parent company Valeant, sources tell Al Borsa. The fund has reportedly made a USD 600 mn offer to acquire 100% of Amoun, and the newspaper is reporting that an unnamed Kuwaiti\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/643065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=643065"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/643065\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/643052"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=643065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=643065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=643065"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=643065"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=643065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}